title: K-ras mutations in the plasma correspond to computed tomographic findings in patients with pancreatic cancer.
authors: Jan
authors: J
authors: Däbritz
authors: Roman
authors: R
authors: Preston
authors: Joachim
authors: J
authors: Hänfler
authors: Helmut
authors: H
authors: Oettle
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood / Q000235:genetics*; D018395:CA-19-9 Antigen / Q000097:blood; D004252:DNA Mutational Analysis; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010190:Pancreatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000235:genetics* / Q000473:pathology; D011237:Predictive Value of Tests; D011379:Prognosis; D011446:Prospective Studies; D011518:Proto-Oncogene Proteins / Q000097:blood / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D060888:Real-Time Polymerase Chain Reaction; D014057:Tomography, X-Ray Computed; D018631:ras Proteins / Q000097:blood / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins